A comparison of gene expression sets between CD34− HSCs from Regnase-1-deleted mice and BM from human AML-M1, M2, and M3 patients indicated significantly similar concordant differences in gene expression between Regnase-1-deleted CD34− HSCs and human AML cells (Fig. 5h). This evidence concerns the gene ZC3H12A and acute myeloid leukemia.